CLINICAL STUDY: ARRHYTHMIAS
Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator
Anne M. Gillis, MD*,*,
Christina Unterberg-Buchwald, MD ,
Herwig Schmidinger, MD ,
Santini Massimo, MD ,
Kevin Wolfe, MD||,
Deborah J. Kavaney, MS¶,
Mary F. Otterness, MS¶,
Stefan H. Hohnloser, MD** GEM III AT Worldwide Investigators
* Foothills Hospital and the University of Calgary, Calgary, Alberta, Canada
Georg-August Universitätskliniken, Göttingen, Germany
Allgemeines Krankenhaus, Vienna, Austria
San Filippo Neri Hospital, Rome, Italy
|| Winnipeg Health Sciences Centre, Winnipeg, Manitoba, Canada
¶ Medtronic Inc., Minneapolis, Minnesota, USA
** J. W. Goethe University, Department of Medicine, Division of Cardiology, Frankfurt, Germany
Manuscript received March 5, 2002;
revised manuscript received May 21, 2002,
accepted June 7, 2002.
* Reprint requests and correspondence: Dr. Anne M. Gillis, Division of Cardiology, The University of Calgary, 3330 Hospital Drive Northwest, Calgary, Alberta, Canada T2N 4N1. amgillis{at}ucalgary.ca
OBJECTIVES: This study evaluated the safety and efficacy of atrial pacing therapies for the treatment and prevention of atrial tachycardia (AT) or atrial fibrillation (AF) in a new dual chamber implantable cardioverter defibrillator (ICD).
BACKGROUND: Patients with an ICD may also experience AT or AF that is amenable to pace termination.
METHODS: The efficacy of atrial antitachycardia pacing (ATP) therapies for atrial tachycardia or atrial fibrillation (AT/AF) was determined in 151 patients after implantation of a GEM III AT ICD (Medtronic Inc., Minneapolis, Minnesota). The percentage of episodes successfully terminated was adjusted for multiple episodes per patient.
RESULTS: A total of 717 of 728 (96%) episodes classified as AT or AF were judged to be appropriate detections. By device classification, atrial ATP terminated 187 of 383 (40% adjusted) episodes classified as AT compared with 65 of 240 episodes classified as AF (26% adjusted, p = 0.013). Atrial Ramp or Burst+ ATP terminated 184 of 378 episodes of AT (39% adjusted), whereas 50-Hz Burst pacing therapy terminated only 12 of 109 episodes of AT (12% adjusted) and 65 of 240 episodes of AF (26% adjusted). If efficacy was defined as termination of AT/AF within 20 s of delivery of the pacing therapy, ATP therapies terminated 139 of 383 (32% adjusted) episodes of AT compared with 34 of 240 episodes of AF (15% adjusted, p = 0.003). Efficacy was dependent on AT cycle length. Frequent transitions between AT and AF predicted inefficacy of atrial ATP (p < 0.001). Ventricular proarrhythmia secondary to atrial ATP was not observed.
CONCLUSIONS: Atrial ATP therapies terminate many episodes of AT without ventricular proarrhythmia. The addition of 50-Hz Burst pacing has minimal efficacy for AT/AF.
|
Abbreviations and Acronyms
| | ACE | | angiotensin-converting enzyme | | AF | | atrial fibrillation | | AT | | atrial tachycardia | | AT/AF | | atrial tachycardia or atrial fibrillation | | ATP | | atrial tachycardia pacing | | CI | | confidence interval | | ICD | | implantable cardioverter defibrillator | | VF | | ventricular fibrillation | | VT | | ventricular tachycardia |
|
This article has been cited by other articles:

|
 |

|
 |
 
F. H. Fenton, S. Luther, E. M. Cherry, N. F. Otani, V. Krinsky, A. Pumir, E. Bodenschatz, and R. F. Gilmour Jr
Termination of Atrial Fibrillation Using Pulsed Low-Energy Far-Field Stimulation
Circulation,
August 11, 2009;
120(6):
467 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Gillis, M. Morck, D. V. Exner, R. S. Sheldon, H. J. Duff, B. L. Mitchell, and G. D. Wyse
Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up
Europace,
August 1, 2009;
11(8):
1041 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
e247 - e346.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
746 - 837.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gulizia, S. Mangiameli, S. Orazi, G. Chiaranda, G. Boriani, G. Piccione, N. DiGiovanni, A. Colletti, C. Puntrello, G. Butera, et al.
Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device
Europace,
July 1, 2006;
8(7):
465 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Musilli and L. Padeletti
Pacemaker selection: time for a rethinking of complex pacing systems?
Eur. Heart J.,
January 2, 2006;
27(2):
132 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vollmann, E. Kollet, L. Lüthje, S. Busse, and C. Unterberg
Comparison of immediate and delayed automatic antitachycardia pacing for the termination of atrial tachyarrhythmias
Europace,
January 1, 2005;
7(3):
248 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|